Phase II Study of Navelbine oral and Arimidex as neo-adjuvant treatment in post-menopausal women with locally advanced breast carcinoma

Phase II Study of Navelbine oral and Arimidex as neo-adjuvant treatment in post-menopausal women with locally advanced breast carcinoma

Hide study title
Status
Status :
Completed
Type of study
Phase II
Min. Age
60
Years old
Max. Age
-
Gender
Female
Therapeutic area :
Oncology
Disease :
Breast cancer
Study medication :
Vinorelbine (NavelbineĀ® Oral)
Phase : Phase II
Start Date :
11 July 2005
End date :
03 February 2009
Study ID : PM0259 CA 217 B0
EudraCT/CTIS number : 2004-000962-11

Results

Public links :

Publication :

Send by email